Moreover, according the results of univariate and multivariate Cox proportional hazard regression analyses, we can confirm that weighted combination of these 4 TCR clones is an independent prognostic predictor for stage II/III patients with an EGFR mutation with NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.